A higher number of cells CD8+ and Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA4)+ and cells expressing CD8 FOXP3 markers, recognized as TILs, was observed in patients with human epidermal growth factor receptor 2 (HER2)-amplified CCA. This evidence concerns the gene ERBB2 and cholangiocarcinoma.